These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 10928093

  • 1. Effects of genistein and 2-methoxyestradiol on matrix metalloproteinases and their inhibitors secreted by Ehrlich ascites tumor cells.
    Fajardo I, Díez E, Rodríguez-Nieto S, Rodríguez-Caso C, Quesada AR, Sánchez-Jiménez F, Medina MA.
    Anticancer Res; 2000; 20(3A):1691-4. PubMed ID: 10928093
    [Abstract] [Full Text] [Related]

  • 2. A comparative study of the effects of genistein and 2-methoxyestradiol on the proteolytic balance and tumour cell proliferation.
    Fajardo I, Quesada AR, Núñez de Castro I, Sánchez-Jiménez F, Medina MA.
    Br J Cancer; 1999 Apr; 80(1-2):17-24. PubMed ID: 10389972
    [Abstract] [Full Text] [Related]

  • 3. Expression of matrix metalloproteinases and their inhibitors by rat NK cells: inhibition of their expression by genistein.
    Kim MH, Albertsson P, Xue Y, Kitson RP, Nannmark U, Goldfarb RH.
    In Vivo; 2000 Apr; 14(5):557-64. PubMed ID: 11125539
    [Abstract] [Full Text] [Related]

  • 4. Role of fibroblast growth factor-2 in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human intestinal myofibroblasts.
    Yasui H, Andoh A, Bamba S, Inatomi O, Ishida H, Fujiyama Y.
    Digestion; 2004 Apr; 69(1):34-44. PubMed ID: 14755151
    [Abstract] [Full Text] [Related]

  • 5. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro.
    Hirata M, Sato T, Tsumagari M, Shimada A, Nakano H, Hashizume K, Ito A.
    Biol Reprod; 2003 Apr; 68(4):1276-81. PubMed ID: 12606436
    [Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H, Shimazu M, Noguchi M, Kishida T, Narumiya H, Sawaguchi K, Noguchi M.
    Oncol Rep; 2003 Apr; 10(1):89-95. PubMed ID: 12469150
    [Abstract] [Full Text] [Related]

  • 7. Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation.
    Reikvam H, Hatfield KJ, Oyan AM, Kalland KH, Kittang AO, Bruserud O.
    Eur J Haematol; 2010 Mar; 84(3):239-51. PubMed ID: 19922462
    [Abstract] [Full Text] [Related]

  • 8. Effects of genistein on the periovulatory expression of messenger ribonucleic acid for matrix metalloproteinases and tissue inhibitors of metalloproteinases in the rat ovary.
    Komar CM, Matousek M, Mitsube K, Mikuni M, Brännström M, Curry TE.
    Reproduction; 2001 Feb; 121(2):259-65. PubMed ID: 11226050
    [Abstract] [Full Text] [Related]

  • 9. Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell.
    Sakaida I, Hironaka K, Kimura T, Terai S, Yamasaki T, Okita K.
    Life Sci; 2004 Mar 19; 74(18):2251-63. PubMed ID: 14987950
    [Abstract] [Full Text] [Related]

  • 10. Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP.
    Becher N, Hein M, Uldbjerg N, Danielsen CC.
    Reprod Biol Endocrinol; 2008 Sep 30; 6():45. PubMed ID: 18826601
    [Abstract] [Full Text] [Related]

  • 11. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases.
    Kim MH.
    J Cell Biochem; 2003 Jun 01; 89(3):529-38. PubMed ID: 12761886
    [Abstract] [Full Text] [Related]

  • 12. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K, Shigemasa K, Nagai N, Ohama K.
    Int J Oncol; 2000 Oct 01; 17(4):673-81. PubMed ID: 10995877
    [Abstract] [Full Text] [Related]

  • 13. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
    Matsunaga Y, Koda M, Murawaki Y.
    Res Commun Mol Pathol Pharmacol; 2004 Oct 01; 115-116():143-50. PubMed ID: 17564313
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ, Chen XM, Cui SW, Cai GY, Shi SZ, Xie YS, Lu Y, Peng LX.
    Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):937-42. PubMed ID: 15329283
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.